Menu
Back to Journals » Drug Design, Development and Therapy » Volume 15
Corrigendum
Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus as-Needed, Short-Acting β2 Agonist: Real-World Effectiveness in patients Without Optimally Controlled asthma (REACT) Study [Corrigendum]
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 3,882 | Dovepress* | 3,683+ | 425 | 4,108 | |
| PubMed Central* | 199 | 87 | 286 | ||
| Totals | 3,882 | 512 | 4,394 | ||
| *Since 12 February 2021 | |||||
View citations on PubMed Central and Google Scholar